• 540
    0

      A drug called sorafenib stopped progression of desmoid tumors for 80 percent of patients taking the drug over a time of two years as a part of phase 3 trial. Desmoid tumors which is well known as aggressive fibromatosis. They grow abnormally in the connective tissue and has a capability of impacting anywhere in ...
  • 678
    0

    Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved Emgality™ (galcanezumab-gnlm) 120 mg injection for the preventive treatment of migraine in adults at 27 September of this month. Migraine is a disabling, neurological disease characterized by recurrent episodes of severe headache accompanied by other symptoms including nausea, vomiting, ...
  • 1204
    0

      The FDA  warns that high doses of vitamin B7, or biotin, in dietary supplements can interfere with hundreds of common lab tests — including some that emergency room doctors rely on to diagnose a heart attack. The problem has led to at least one death.Biotin is in many multivitamins. It’s also sold in formulas ...
  • 523
    0

    The Food and Drug Administration has approved the drug Krintafel (tafenoquine) for the treatment of malaria following a Priority Review this past Friday. The drug, developed by GSK Pharmaceuticals and Medicines for Malaria Venture, is a single dose medication designed for people who’ve had malaria before. It prevents the relapse of malaria caused by Plasmodium ...
  • 711
    0

    U.S. FDA approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+). Ogivri is the first biosimilar approved in the U.S. for the treatment of breast cancer or stomach cancer and the second ...
  • 721
    0

    The U.S. Food and Drug Administration (FDA) announced on November 15 the approval of a device called the Neuro-Stim System Bridge (NSS-2 Bridge), which is meant to help reduce the symptoms of opioid withdrawal. It’s the first medical device of its kind that’s been given the FDA’s blessing. The NSS-2 Bridge is a relatively simple ...
  • 744
    0

    The U.S. Food and Drug Administration approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed ...
  • 650
    0

    FDA has approved clinical trials in Samford health for its institution second ever adipose-derived stem cell clinical trial which is designed to treat non-healing leg ulcers. The trial has started in September of this year. The trial includes the study participants with an age above 18 with a leg wound 3- 25 cm and with ...
  • 522
    0

    U.S. Food and Drug Administration cleared the Senhance System, a new robotically-assisted surgical device (RASD) that can help facilitate minimally invasive surgery. “Minimally invasive surgery helps reduce pain, scarring and recovery time after surgery,” said Binita Ashar, M.D., director of the Division of Surgical Devices in the FDA’s Center for Devices and Radiological Health. “RASD ...
  • 543
    0

    An experimental gene therapy for a rare hereditary form of blindness is a step closer to reality. An FDA advisory panel voted unanimously Thursday to recommend approval of a groundbreaking treatment for people with a faulty gene that impairs vision. It would be the first gene therapy in the U.S. for an inherited disease. The ...